6505-01-367-5244 Amlodipine besylate tablets
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 23, 2026
- Last price paid
- …
- Standard price
- $9.08 per BT
- DLA's catalog price, not a price paid
- Approved sources
- 3
- Awards on record
- 194
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Amlodipine besylate tablets
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 14-NOV-92
- Unit
- BT
- NSN
- 6505-01-367-5244
- NIIN
- 01-367-5244
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| VIATRIS SPECIALTY LLC | 10SP2 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC58151-0354-77 | DLA approved-source file |
| GREENSTONE LLC | 48KC0 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC59762-2010-09 | DLA approved-source file |
| 6YA44 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC68382-0122-16 | DLA approved-source file | |
| 86491 | A (Active) | 3 (Design control reference) / 9 (Was the design control reference) | NDC00069-1530-68 | FLIS part list | |
| 6GFC4 | A (Active) | 5 (Secondary reference) / 9 (Was the design control reference) | NDC76282-0238-90 | FLIS part list | |
| 86491 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | NORVASC | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
2 contracts DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX25D8022 | CARDINAL HEALTH, INC. | SPE2DX | $76,117,432 | March 6, 2035 | INDEFINITE DELIVERY / REQUIREMENTS | No | 28 | September 13, 2026 |
| SPE2DX15D0022 | CARDINAL HEALTH, INC. | SPE2DX | $20,000,000 | June 30, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 4 | December 11, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909220 (Crdiovsclr med,cont amiodarone,its salts,dses/pkg)
- PINC
- 0049421
- Criticality (CRIT CD)
- X
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| YD01 | Israel (YD) | ||||||
| YJ01 | Singapore (YJ) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 30-JUN-2026 | BT | $427.03 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BT | $427.03 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BT | $427.03 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BT | $9.08 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0368DIBBS only | 6505-01-367-5244 | Amlodipine besylate tablets | 4 | BT | $9.08 per BT | … | … | No set-aside | No | November 15, 2026 | November 23, 20267 days left |
→ These RFQs in the DIBBS list
Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 113 days (128 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
194 award lines since 2013, 2 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 00E55Cardinal Health, Inc. | 193 | November 9, 2026 |
| 0AG09SZY HOLDINGS, LLC | 1 | June 26, 2025 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 29 | 1 |
| 2025 | 33 | 2 |
| 2024 | 31 | 1 |
| 2023 | 18 | 1 |
| 2022 | 26 | 1 |
| 2021 | 33 | 1 |
| 2020 | 5 | 1 |
| 2019 | 3 | 1 |
| 2018 | 4 | 1 |
| 2016 | 3 | 1 |
| 2015 | 3 | 1 |
| 2014 | 1 | 1 |
| 2013 | 5 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | CARDINAL HEALTH, INC. | $129,653 | 183 |
| 2 | SZY HOLDINGS, LLC | $116 | 1 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2D926F8281From the item's award history | August 17, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F8285From the item's award history | August 17, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F8088From the item's award history | August 9, 2026 | CARDINAL HEALTH, INC. | $63 |
| SPE2D926F7737From the item's award history | July 30, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F7034From the item's award history | July 2, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F6638From the item's award history | June 12, 2026 | CARDINAL HEALTH, INC. | $13 |
| SPE2D926F6038From the item's award history | May 23, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F5879From the item's award history | May 19, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F5291From the item's award history | April 29, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F5026From the item's award history | April 23, 2026 | CARDINAL HEALTH, INC. | $42 |
| SPE2D926F5030From the item's award history | April 23, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F4898From the item's award history | April 19, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F4648From the item's award history | April 13, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F4600From the item's award history | April 10, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F4040From the item's award history | March 27, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F3976From the item's award history | March 26, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F4035From the item's award history | March 26, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F2940From the item's award history | February 24, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F2708From the item's award history | February 11, 2026 | CARDINAL HEALTH, INC. | $42 |
| SPE2D926F2721From the item's award history | February 11, 2026 | CARDINAL HEALTH, INC. | $8 |
| SPE2D926F2671From the item's award history | February 10, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F2516From the item's award history | February 6, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F2329From the item's award history | January 29, 2026 | CARDINAL HEALTH, INC. | $4 |
| SPE2D926F2040From the item's award history | January 22, 2026 | CARDINAL HEALTH, INC. | $13 |
| SPE2D926F1824From the item's award history | January 14, 2026 | CARDINAL HEALTH, INC. | $4 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.